4//SEC Filing
Quinlan Paul T 4
Accession 0001062993-24-006510
CIK 0001042074other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 4:02 PM ET
Size
6.9 KB
Accession
0001062993-24-006510
Insider Transaction Report
Form 4
Quinlan Paul T
General Counsel
Transactions
- Exercise/Conversion
Common Stock
2024-03-13$7.89/sh+41,824$329,991→ 70,262 total - Exercise/Conversion
Employee Stock Option (right to buy)
2024-03-13−41,824→ 8,872 totalExercise: $7.89Exp: 2030-10-11→ Common Stock (41,824 underlying)
Footnotes (1)
- [F1]The option grant vests as to 1/4 of the underlying shares on October 12, 2021 and as to 1/48 of the underlying shares monthly thereafter.
Issuer
CymaBay Therapeutics, Inc.
CIK 0001042074
Entity typeother
Related Parties
1- filerCIK 0001333277
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 4:02 PM ET
- Size
- 6.9 KB